-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BQiH8pGfIM1N5mudyKmRzpBu9L0v3hUd45K+2/heESfhG26mEmNgyfFjhRI+/Nro YjbZs1ZOo33jyx9fKRxaZQ== 0001209191-08-019826.txt : 20080324 0001209191-08-019826.hdr.sgml : 20080324 20080324110748 ACCESSION NUMBER: 0001209191-08-019826 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080312 FILED AS OF DATE: 20080324 DATE AS OF CHANGE: 20080324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burge Daniel J CENTRAL INDEX KEY: 0001429726 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33054 FILM NUMBER: 08706214 BUSINESS ADDRESS: BUSINESS PHONE: 2068380500 MAIL ADDRESS: STREET 1: 2401 4TH AVE., SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trubion Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001298521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 14TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2068380500 MAIL ADDRESS: STREET 1: 2401 14TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 3 1 doc3.xml FORM 3 SUBMISSION X0202 3 2008-03-12 0 0001298521 Trubion Pharmaceuticals, Inc TRBN 0001429726 Burge Daniel J 2401 4TH AVE., SUITE 1050 SEATTLE WA 98121 0 1 0 0 Chief Medical Officer, SVP Common Stock 25745 I By Trust Common Stock 27108 I By Trust Stock Option (right to buy) 0.314 2014-12-16 Common Stock 21326 D Stock Option (right to buy) 0.314 2015-02-03 Common Stock 7108 D Stock Option (right to Buy) 2.697 2015-11-30 Common Stock 10663 D Stock Option (right to buy) 0.314 2014-05-27 Common Stock 36045 D Stock Option (right to buy) 6.522 2016-01-25 Common Stock 7335 D Stock Option (right to buy) 6.522 2016-03-08 Common Stock 10663 D Stock Option (right to buy) 6.522 2016-02-24 Common Stock 23919 D Stock Option (right to buy) 0.314 2015-04-28 Common Stock 584 D Stock Option (right to buy) 8.98 2018-01-31 Common Stock 52000 D Shares held of record by Sybil Burge Irrevocable Trust, of which the reporting person is a trustee and beneficiary. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Shares held of record by Daniel Burge Irrevocable Trust, of which the reporting person's spouse is trustee and spouse and minor children are beneficiaries. The reporting person disclaims beneficial ownership of such shares. Vests at the rate of 25% on July 13, 2005, and 1/48th monthly thereafter, such that all of the shares will be fully vested as of July 13, 2008. Vests at the rate of approximately 14% on March 31, 2005, 27% on November 1, 2005, 16% on September 10, 2007 and the remaining shares monthly thereafter, such that all shares will be fully vested as of March 31, 2008. Fully vested as of January 1, 2007. Vests at the rate of 25% on January 1, 2007, and 1/48th monthly thereafter, such that all of the shares will be fully vested as of January 1, 2010. Fully vested as of January 1, 2006. Vests at the rate of 1/48th on February 1, 2008, and 1/48th monthly thereafter, such that all of the shares will be fully vested as of January 1, 2012. /s/ Kathleen Deeley, Attorney-in-fact 2008-03-24 EX-24.3_232595 2 poa.txt POA DOCUMENT POWER OF ATTORNEY The undersigned hereby constitutes and appoints Michelle Burris and Kathleen Deeley, or either of them, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Trubion Pharmaceuticals, Inc. (the "Company"), Forms 3, 4s and 5s in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Forms 3, 4s and 5s and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform each and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. The undersigned agrees that such attorney-in-fact may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact. The undersigned also agrees to indemnify and hold harmless the Company and such attorney-in-fact against any losses, claims, damages or liabilities (or actions in these respects) that arise out of or are based on any untrue statement or omission of necessary facts in the information provided by the undersigned to such attorney-in-fact for purposes of executing, acknowledging, delivering and filing Forms 3, 4s or 5s (including amendments thereto) and agrees to reimburse the Company and such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4s and 5s with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 10th day of March, 2008. /s/ DANIEL J. BURGE Daniel J. Burge -----END PRIVACY-ENHANCED MESSAGE-----